Idiopathic Pulmonary Fibrosis: Cellular Heterogeneity, Mechanisms, and Therapeutic Implications
MedComm · 2025-12 · 6 (12)
DOI: 10.1002/mco2.70521 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 15.12.2025. Verfasst von Lin Zuo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 232 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease characterized by excessive extracellular matrix (ECM) deposition and irreversible alveolar destruction. Despite advances in antifibrotic therapies, the underlying pathogenic mechanisms remain incompletely understood. Recent multiomic studies have revealed that IPF arises from aberrant communication among epithelial, mesenchymal, immune, and vascular cells within the fibrotic microenvironment, rather than from isolated cellular dysfunction. However, the dynamic intercellular networks and spatiotemporal regulation driving disease progression remain poorly defined. This review integrates recent single‐cell RNA sequencing and spatial transcriptomic discoveries to delineate key pathogenic cell populations—including aberrant basaloids and IPF‐related alveolar type 2 cells (IR_AT2), CTHRC1 + and meflin + fibroblasts, and SPP1 hi macrophages—and their signaling crosstalk through pathways such as transforming growth factor β(TGF‐β), Hippo, and Hedgehog. We further discuss how ECM feedback loops and immune‐metabolic remodeling reinforce fibrogenesis and explore emerging therapeutic targets derived from these mechanisms. By synthesizing multidimensional data into a cellular and molecular framework, this review advances the understanding of IPF pathogenesis and provides a conceptual foundation for biomarker‐guided precision therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China.
ORCID-Profile: Lin Zuo
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zuo, L., Liu, Q., Ye, D., Fan, J., & Wu, L. (2025). Idiopathic Pulmonary Fibrosis: Cellular Heterogeneity, Mechanisms, and Therapeutic Implications. MedComm, 6(12). https://doi.org/10.1002/mco2.70521
Vancouver
Zuo L, Liu Q, Ye D, Fan J, Wu L. Idiopathic Pulmonary Fibrosis: Cellular Heterogeneity, Mechanisms, and Therapeutic Implications. MedComm. 2025;6(12). doi:10.1002/mco2.70521
BibTeX
@article{Zuo2025,
author = {Zuo, Lin and Liu, Qiongliang and Ye, Defeng and Fan, Jiang and Wu, Liang},
title = {Idiopathic Pulmonary Fibrosis: Cellular Heterogeneity, Mechanisms, and Therapeutic Implications},
journal = {MedComm},
year = {2025},
volume = {6},
number = {12},
doi = {10.1002/mco2.70521}
}
EUVIMED